Product: | Pidotimod | |
---|---|---|
Catalog Number: | 32281 | |
CAS Number: | 121808-62-6 | |
Pricing: |
|
|
Formula: | C9H12N2O4S | |
Chemical Purity: | >98% | |
Molecular Weight: | 244.27 | |
Structure: | ||
Appearance: | White powder | |
Category: | API Compounds | |
Stability: | Stable under recommended storage conditions | |
Storage: |
Store at 4°C |
|
Literature References: |
Migliorati, G., et al. 1994. Arzneimittelforschung. 44: 1421-1424; Gourgiotis, D., et al. 2004. J Asthma. 41: 285-287; Riboldi, P., et al. 2009. Int J Immunopathol Pharmacol. 22: 255-262; Giagulli, C., et al. 2009. Int. Immunopharmacol. 9: 1366-1373. |
|
MSDS: | ||
Description: |
Pidotimod is a synthetic dipeptide with immunological modulatory activity on both the adaptive and innate immune responses. This compound has been shown to induce dendritic cell maturation and up-regulate the expression of HLA-DR and co-stimulatory molecules CD83 and CD86, which are integral to communication with adaptive immunity cells. Pidotimod has also been shown to stimulate dendritic cells to release pro-inflammatory molecules such as MCP-1 and TNF-α cytokines, and to inhibit thymocyte apoptosis caused by a variety of apoptosis inducing molecules |